Earnings calls

Archean Chemical concall ledger

Every earnings call for ACI — management tone, guidance, KPIs and promise tracking, quarter by quarter.

ACI · 6 transcripts · Chemicals · latest Q4 FY26

Q4 FY26Published 13 May 2026Call held 13 May 2026

ACI Q4 FY26 Earnings Call Transcript & Analysis

Standalone Total Revenue₹1,088.8 cr+2% YoYStandalone EBITDA₹66.4 cr−34% YoYStandalone EBITDA Margin21.79%Standalone PAT₹29.8 crStandalone Total Income₹304.7 cr−9% YoY

Standalone Total Revenue (FY26) ₹1,089 cr (+2% YoY); Standalone EBITDA (Q4) ₹66 cr (−34% YoY); Standalone EBITDA Margin (Q4) 21.79%. Full year FY26 standalone revenue grew 2% YoY to INR 1,088.8 crores.

Read full transcript & analysis

Q3 FY26Published 06 Feb 2026Call held 06 Feb 2026

ACI Q3 FY26 Earnings Call Transcript & Analysis

Standalone Total Revenue7,840 million+7% YoYStandalone EBITDA698.6 million−27% YoYStandalone EBITDA Margin27%Standalone Net Profit343 millionStandalone Total Income2,608.1 million+2% YoY

Standalone Total Revenue (9M FY26) 7840.0 million (+7% YoY); Standalone EBITDA (Q3 FY26) 698.6 million (−27% YoY); Standalone EBITDA Margin (Q3 FY26) 27.0%. Q3 FY26 standalone total income grew 2.4% YoY to INR 2,608.1 million.

Read full transcript & analysis

Q2 FY26Published 18 Nov 2025Call held 18 Nov 2025

ACI Q2 FY26 Earnings Call Transcript & Analysis

Standalone Revenue2,317.8 million−8% YoYStandalone EBITDA759.9 million−15% YoYStandalone EBITDA Margin33%Standalone Net Profit384.6 million

Standalone Revenue (Q2 FY26) 2317.8 million (−8% YoY); Standalone EBITDA (Q2 FY26) 759.9 million (−15% YoY); Standalone EBITDA Margin (Q2 FY26) 33.0%. H1 FY26 standalone revenue grew 10% to INR 5,232.3 million.

Read full transcript & analysis

Q1 FY26Published 31 Jul 2025Call held 31 Jul 2025

ACI Q1 FY26 Earnings Call Transcript & Analysis

Consolidated Revenue₹300.59 cr+30% YoYConsolidated EBITDA₹86.32 crConsolidated EBITDA Margin28.72%Consolidated Net Profit₹40.14 cr

Consolidated Revenue ₹301 cr (+30% YoY); Consolidated EBITDA ₹86 cr; Consolidated EBITDA Margin 28.72%. Consolidated Revenue of ₹300.59 crores, up 30% YoY.

Read full transcript & analysis

Q4 FY25Published 07 May 2025Call held 07 May 2025

ACI Q4 FY25 Earnings Call Transcript & Analysis

Total Revenue₹333.33 crEBITDA₹101.12 crEBITDA Margin30.3%Net Profit₹58.3 cr

Total Revenue (Q4 FY25) ₹333 cr; EBITDA (Q4 FY25) ₹101 cr; EBITDA Margin (Q4 FY25) 30.3%. Q4 FY25 Total Revenue stood at INR 333.33 crores.

Read full transcript & analysis

Q3 FY25Published 12 Feb 2025Call held 12 Feb 2025

ACI Q3 FY25 Earnings Call Transcript & Analysis

EBITDA963 millionEBITDA Margin38%Total Income2,547 million

EBITDA (Q3 FY25) 963 million; EBITDA Margin (Q3 FY25) 38%; Total Income (Q3 FY25) 2547 million. Q3 FY25 Total income increased to Rs. 2,547 million, up from Rs. 2,520 million in Q2 FY25.

Read full transcript & analysis